New York State Common Retirement Fund
ACTU

New York State Common Retirement Fund’s Actuate Therapeutics ACTU Stock Holding History

New York State Common Retirement Fund’s Portfolio ACTU Stock Details ACTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6,200
Closed -$17K – 3350
2026
Q1 		$17K Hold
6,200
– – ﹤0.01% 3033
2025
Q4 		$37.9K Hold
6,200
– – ﹤0.01% 2978
2025
Q3 		$41.5K Sell
6,200
-11,000
-64% -$79.7K ﹤0.01% 2998
2025
Q2 		$105K Buy
+17,200
New +$150K ﹤0.01% 2570

Other funds holding ACTU

GG
Gleason Group Prospect, Kentucky $1.15B AUM 21.11% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
AA
ACT Advisors Asheville, North Carolina $301M AUM 23.36% 1-Year Est. Return
SFS
Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return
GRWP
Green Ridge Wealth Planning Montville, New Jersey $238M AUM
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

New York State Common Retirement Fund's ACTU Position: Q2 2026 in Review

New York State Common Retirement Fund sold out of Actuate Therapeutics (ACTU) in Q2 2026, closing a stake of 6,200 shares — an estimated $17K sold.

New York State Common Retirement Fund first reported a position in ACTU in Q2 2025 and held it in 4 quarters. The position peaked at $105K in Q2 2025. 12 funds tracked by Wall St. Rank hold ACTU as of Q2 2026.

  • New York State Common Retirement Fund reported no remaining Actuate Therapeutics position as of Q2 2026 after selling out during the quarter.
  • New York State Common Retirement Fund sold 6,200 Actuate Therapeutics shares in Q2 2026, an estimated $17K.
  • New York State Common Retirement Fund first reported a position in Actuate Therapeutics in Q2 2025 and held it in 4 quarters.
  • New York State Common Retirement Fund's Actuate Therapeutics position peaked at $105K in Q2 2025.
  • 12 funds tracked by Wall St. Rank held Actuate Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.